HomeLYRA • NASDAQ
add
Lyra Therapeutics Inc
Previous close
$7.15
Day range
$6.79 - $7.32
Year range
$3.81 - $37.50
Market cap
11.47M USD
Avg Volume
38.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
BNN Bloomberg
44 minutes ago
Basic materials stocks weigh on S&P/TSX composite while U.S. markets rise
1.15%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 183.00K | -69.40% |
Operating expense | 3.50M | -31.87% |
Net income | -7.44M | 84.55% |
Net profit margin | -4.06K | 49.51% |
Earnings per share | -5.22 | 59.70% |
EBITDA | -8.30M | 53.00% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.78M | -55.87% |
Total assets | 52.57M | -44.42% |
Total liabilities | 50.95M | -19.89% |
Total equity | 1.62M | — |
Shares outstanding | 1.64M | — |
Price to book | 7.15 | — |
Return on assets | -38.70% | — |
Return on capital | -59.08% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -7.44M | 84.55% |
Cash from operations | -6.59M | 67.02% |
Cash from investing | -2.00K | -100.01% |
Cash from financing | 4.64M | 5,314.61% |
Net change in cash | -1.95M | -112.11% |
Free cash flow | -3.97M | 54.56% |
About
Founded
2005
Headquarters
Website
Employees
30
